|
|
Vaccine Detail
|
Aflunov |
| Vaccine Information |
- Vaccine Name: Aflunov
- Target Pathogen: Influenza virus
- Target Disease: Influenza (flu)
- Product Name: prepandemic influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted)
- Tradename: Aflunov
- Manufacturer: Novartis
- Vaccine Ontology ID: VO_0004280
- Type: Inactivated or "killed" vaccine
- Status: Licensed
- Location Licensed: Europe
- Host Species for Licensed Use: Human
- Antigen: A/Vietnam/1194/2004 (H5N1)-like strain (NIBRG-14) (Aflunov Product Info).
- Adjuvant:
- Immunization Route: Intramuscular injection (i.m.)
- Storage: 2°C - 8°C
- Approved Age for Licensed Use: 18 years and older (Aflunov Product Info).
- Contraindication: History of an anaphylactic (i.e. life-threatening) reaction to any of the constituents or trace residues (egg and chicken proteins, ovalbumin, kanamycin and neomycin sulphate, formaldehyde and cetyltrimethylammonium bromide (CTAB)) of this vaccine (Aflunov Product Info).
|
| Host Response |
|
|
| References |
Aflunov Product Info: Aflunov Product Information [http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/002094/WC500101080.pdf]
|
|
